Vascular reactivity in diabetes mellitus.
Dandona
Paresh
P
Division of Endocrinology and Metabolism, State University of New York at Buffalo, USA. pdandona@KaleidaHealth.org
D050197:Atherosclerosis / Q000209:etiology / Q000503:physiopathology; D003922:Diabetes Mellitus, Type 1 / Q000503:physiopathology; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000503:physiopathology*; D003925:Diabetic Angiopathies / Q000209:etiology / Q000503:physiopathology; D004730:Endothelium, Vascular / Q000503:physiopathology; D011464:Epoprostenol / Q000502:physiology; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use; D007249:Inflammation; D007328:Insulin / Q000502:physiology; D009569:Nitric Oxide / Q000502:physiology; D018384:Oxidative Stress; D045162:Thiazolidinediones / Q000494:pharmacology / Q000627:therapeutic use; D014661:Vasoconstriction / Q000502:physiology; D014664:Vasodilation / Q000502:physiology*
D007004:Hypoglycemic Agents; D007328:Insulin; D045162:Thiazolidinediones; D009569:Nitric Oxide; D011464:Epoprostenol